Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Funds

Offices

Montreal, CAN
1 Westmount Square
Suite 800
Montreal, H3Z 2P9 , CAN

People

General Partner

Tags

AgeChem Venture Fund

The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.

Recent Milestones

Investments

Company Date Round Size Participants
Akebia Therapeutics 6/2013Series C$41M9
Alethia BioTherapeutics 11/2012Series B$4.7M3
Aerpio Therapeutics 8/2012Series A$27M6
Akebia Therapeutics 1/2012Series B$4.1M7
Sorbent Therapeutics 6/2011Series B$36M5
Akebia Therapeutics 4/2011Series B$22M7
Conatus Pharmaceuticals 2/2011Series B$20M6
Sorbent Therapeutics 9/2010Series B$21.8M4
Alethia BioTherapeutics 9/2010Series A$9.2M4
Altair Therapeutics 2/2010Series B$17M4
Sonexa Therapeutics 1/2008Series A$30M5

Videos

Sources

  1. Akebia Therapeutics Completes $41M Series C Financing (finsmes.com) [edit]
  2. Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program (finance.yahoo.com) [edit]
  3. Aerpio Therapeutics Closes $27M Series A Financing (finsmes.com) [edit]
  4. Akebia Therapeutics Raises $4.1M in Series B Financing (finsmes.com) [edit]
  5. Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million (money.msn.com) [edit]
  6. AKEBIA COMPLETES $22M SERIES B FINANCING (akebia.com) [edit]
  7. Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing (pharmalive.com) [edit]
  8. Sorbent Raises $21.8M Series B, Names New CEO (fis.dowjones.com) [edit]
  9. Alethia Biotherapeutics Brings Home $9.2M Series A (fis.dowjones.com) [edit]
  10. Altair Therapeutics, Inc.: Series B $17M (onbiovc.com) [edit]
  11. Sonexa Therapeutics, Inc. Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments (biospace.com) [edit]
Edit This Page
Last Edited 4/2/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy